New York, New York–(Newsfile Corp. – August 12, 2021) – Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:
- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
The company or its officers and directors made false and/or misleading statements and/or failed to disclose that: (1) the Company had deficient disclosure controls and procedures with respect to its marketing of DSUVIA; (2) as a result, the Company had been making false or misleading claims and representations about the risks and efficacy of DSUVIA in certain advertisements and displays; (3) the foregoing conduct subjected the Company to increased regulatory scrutiny and enforcement; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you own ACRX, please contact Fletcher Moore, Esq. by email at [email protected] or telephone at (212) 709-8245. There is no cost to you. Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers.
Please visit http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/
Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
[email protected]
(212) 709-8245
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92998